schliessen

Filtern

 

Bibliotheken

Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment

Cardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease... Full description

Journal Title: The Lancet (British edition) 2006, Vol.368 (9548), p.1651-1659
Main Author: Danaei, Goodarz
Other Authors: Lawes, Carlene MM , Vander Hoorn, Stephen , Murray, Christopher JL , Ezzati, Majid
Format: Electronic Article Electronic Article
Language: English
Subjects:
Quelle: Alma/SFX Local Collection
Publisher: England: Elsevier Ltd
ID: ISSN: 0140-6736
Link: https://www.ncbi.nlm.nih.gov/pubmed/17098083
Zum Text:
SendSend as email Add to Book BagAdd to Book Bag
Staff View
recordid: cdi_proquest_miscellaneous_68135435
title: Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
format: Article
creator:
  • Danaei, Goodarz
  • Lawes, Carlene MM
  • Vander Hoorn, Stephen
  • Murray, Christopher JL
  • Ezzati, Majid
subjects:
  • Abridged Index Medicus
  • Adult
  • Age Distribution
  • Aged
  • Blood Glucose
  • Blood sugar
  • Cardiovascular disease
  • Complications and side effects
  • Diabetes
  • Diabetes Mellitus - mortality
  • Female
  • Global Health
  • Health aspects
  • Health Surveys
  • Heart diseases
  • Humans
  • Hyperglycemia
  • Male
  • Measurement
  • Middle Aged
  • Mortality
  • Myocardial ischemia
  • Myocardial Ischemia - blood
  • Myocardial Ischemia - mortality
  • Population Surveillance - methods
  • Risk Assessment
  • Risk factors
  • Sex Distribution
  • Stroke (Disease)
  • Stroke - blood
  • Stroke - mortality
  • Studies
  • Systematic review
ispartof: The Lancet (British edition), 2006, Vol.368 (9548), p.1651-1659
description: Cardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide. We used population distribution of fasting plasma glucose to measure exposure to higher-than-optimum blood glucose. We collated exposure data in 52 countries from individual-level records in population health surveys, systematic reviews, and data provided by investigators. Relative risks for ischaemic heart disease and stroke mortality were from a meta-analysis of more than 200 000 participants in the Asia-Pacific region, with adjustment for other cardiovascular risk factors. In addition to 959 000 deaths directly assigned to diabetes, 1 490 000 deaths from ischaemic heart disease and 709 000 from stroke were attributable to high blood glucose, accounting for 21% and 13% of all deaths from these conditions. 1·8 million of these 2·2 million cardiovascular deaths (84%) were in low-and-middle-income countries (1 224 000 for ischaemic heart disease, 623 000 for stroke). 792 000 (53%) of deaths from ischaemic heart disease and 345 000 (49%) from stroke that were attributable to high blood glucose were in men. Largest numbers of deaths attributable to this risk factor from ischaemic heart disease were in low-and-middle-income countries of South Asia (548 000) and Europe and Central Asia (313 000), and from stroke in South Asia (215 000) and East Asia and Pacific (190 000). Higher-than-optimum blood glucose is a leading cause of cardiovascular mortality in most world regions. Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated.
language: eng
source: Alma/SFX Local Collection
identifier: ISSN: 0140-6736
fulltext: fulltext
issn:
  • 0140-6736
  • 1474-547X
url: Link


@attributes
NO1
SEARCH_ENGINEprimo_central_multiple_fe
SEARCH_ENGINE_TYPEPrimo Central Search Engine
RANK2.6036334
LOCALfalse
PrimoNMBib
record
control
sourceidgale_proqu
recordidTN_cdi_proquest_miscellaneous_68135435
sourceformatXML
sourcesystemPC
galeidA196104696
sourcerecordidA196104696
originalsourceidFETCH-LOGICAL-c588t-ba7d8766e04a6e73650879e78b329e3cbde4c9d3f3fe3da4eac7c275ddf980e33
addsrcrecordideNqNktFq1UAQhoMo9lh9BGVREAVTN02ym-iFlKJVKHihgnfLZneSs22SPd3ZFPo6PqmTcw56WsSWXCQTvv8fZuZPkqcZP8h4Jt5-41nBUyFz8YqL16KWnKp7ySIrZJGWhfx5P1n8QfaSR4hnnPNC8PJhspdJXle8yhfJr5PeN7pnerQsQOf8SMXgQ9S9i1esDX5gDs1Sw-AMW4IOkVmHoBHWGozBn9NnjME1U9RNDyx6tnTdEkIal3pM_Sq6YRpY03tvWddPxpPY-NHAGIOO1PMdlcNKz8UlsODwnGlEQBwIeZw8aHWP8GT73k9-fPr4_fhzevr15Mvx0WlqyqqKaaOlraQQwAstgIYueSVrkFWTH9aQm8ZCYWqbt3kLudUFaCPNoSytbWkXkOf7ycuN7yr4iwkwqoEmh77XI_gJlaiyvCzyksDnN8AzPwVaHKqsrrmQRBH0YgN1ugflxtbTrGZ2VEdZLTI6RS3-T9EVS8nF3PDgHxQ9dr6KH6F19P-a7d0EOx3e7AiaCd1I23cj0h0jdnpCvO5_F3zHvdzgJnjEAK1aBTfocKUyruY0q3Wa1RxVxYVap1nNbZ5tFz01A9i_qm18CXh_w9i4uE4Uzev6W-0_bNRAqbp0EBQaBxRL6wKYqKx3tzj8Bl-hGBk
sourcetypeAggregation Database
isCDItrue
recordtypearticle
pqid199067543
display
typearticle
titleGlobal and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
sourceAlma/SFX Local Collection
creatorDanaei, Goodarz ; Lawes, Carlene MM ; Vander Hoorn, Stephen ; Murray, Christopher JL ; Ezzati, Majid
creatorcontribDanaei, Goodarz ; Lawes, Carlene MM ; Vander Hoorn, Stephen ; Murray, Christopher JL ; Ezzati, Majid
descriptionCardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide. We used population distribution of fasting plasma glucose to measure exposure to higher-than-optimum blood glucose. We collated exposure data in 52 countries from individual-level records in population health surveys, systematic reviews, and data provided by investigators. Relative risks for ischaemic heart disease and stroke mortality were from a meta-analysis of more than 200 000 participants in the Asia-Pacific region, with adjustment for other cardiovascular risk factors. In addition to 959 000 deaths directly assigned to diabetes, 1 490 000 deaths from ischaemic heart disease and 709 000 from stroke were attributable to high blood glucose, accounting for 21% and 13% of all deaths from these conditions. 1·8 million of these 2·2 million cardiovascular deaths (84%) were in low-and-middle-income countries (1 224 000 for ischaemic heart disease, 623 000 for stroke). 792 000 (53%) of deaths from ischaemic heart disease and 345 000 (49%) from stroke that were attributable to high blood glucose were in men. Largest numbers of deaths attributable to this risk factor from ischaemic heart disease were in low-and-middle-income countries of South Asia (548 000) and Europe and Central Asia (313 000), and from stroke in South Asia (215 000) and East Asia and Pacific (190 000). Higher-than-optimum blood glucose is a leading cause of cardiovascular mortality in most world regions. Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated.
identifier
0ISSN: 0140-6736
1EISSN: 1474-547X
2DOI: 10.1016/S0140-6736(06)69700-6
3PMID: 17098083
4CODEN: LANCAO
languageeng
publisherEngland: Elsevier Ltd
subjectAbridged Index Medicus ; Adult ; Age Distribution ; Aged ; Blood Glucose ; Blood sugar ; Cardiovascular disease ; Complications and side effects ; Diabetes ; Diabetes Mellitus - mortality ; Female ; Global Health ; Health aspects ; Health Surveys ; Heart diseases ; Humans ; Hyperglycemia ; Male ; Measurement ; Middle Aged ; Mortality ; Myocardial ischemia ; Myocardial Ischemia - blood ; Myocardial Ischemia - mortality ; Population Surveillance - methods ; Risk Assessment ; Risk factors ; Sex Distribution ; Stroke (Disease) ; Stroke - blood ; Stroke - mortality ; Studies ; Systematic review
ispartofThe Lancet (British edition), 2006, Vol.368 (9548), p.1651-1659
rights
02006 Elsevier Ltd
1COPYRIGHT 2006 Elsevier B.V.
2Copyright Lancet Ltd. Nov 11-Nov 17, 2006
lds50peer_reviewed
citedbyFETCH-LOGICAL-c588t-ba7d8766e04a6e73650879e78b329e3cbde4c9d3f3fe3da4eac7c275ddf980e33
citesFETCH-LOGICAL-c588t-ba7d8766e04a6e73650879e78b329e3cbde4c9d3f3fe3da4eac7c275ddf980e33
links
openurl$$Topenurl_article
openurlfulltext$$Topenurlfull_article
thumbnail$$Usyndetics_thumb_exl
backlink$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17098083$$D View this record in MEDLINE/PubMed
search
creatorcontrib
0Danaei, Goodarz
1Lawes, Carlene MM
2Vander Hoorn, Stephen
3Murray, Christopher JL
4Ezzati, Majid
title
0Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
1The Lancet (British edition)
addtitleLancet
descriptionCardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide. We used population distribution of fasting plasma glucose to measure exposure to higher-than-optimum blood glucose. We collated exposure data in 52 countries from individual-level records in population health surveys, systematic reviews, and data provided by investigators. Relative risks for ischaemic heart disease and stroke mortality were from a meta-analysis of more than 200 000 participants in the Asia-Pacific region, with adjustment for other cardiovascular risk factors. In addition to 959 000 deaths directly assigned to diabetes, 1 490 000 deaths from ischaemic heart disease and 709 000 from stroke were attributable to high blood glucose, accounting for 21% and 13% of all deaths from these conditions. 1·8 million of these 2·2 million cardiovascular deaths (84%) were in low-and-middle-income countries (1 224 000 for ischaemic heart disease, 623 000 for stroke). 792 000 (53%) of deaths from ischaemic heart disease and 345 000 (49%) from stroke that were attributable to high blood glucose were in men. Largest numbers of deaths attributable to this risk factor from ischaemic heart disease were in low-and-middle-income countries of South Asia (548 000) and Europe and Central Asia (313 000), and from stroke in South Asia (215 000) and East Asia and Pacific (190 000). Higher-than-optimum blood glucose is a leading cause of cardiovascular mortality in most world regions. Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated.
subject
0Abridged Index Medicus
1Adult
2Age Distribution
3Aged
4Blood Glucose
5Blood sugar
6Cardiovascular disease
7Complications and side effects
8Diabetes
9Diabetes Mellitus - mortality
10Female
11Global Health
12Health aspects
13Health Surveys
14Heart diseases
15Humans
16Hyperglycemia
17Male
18Measurement
19Middle Aged
20Mortality
21Myocardial ischemia
22Myocardial Ischemia - blood
23Myocardial Ischemia - mortality
24Population Surveillance - methods
25Risk Assessment
26Risk factors
27Sex Distribution
28Stroke (Disease)
29Stroke - blood
30Stroke - mortality
31Studies
32Systematic review
issn
00140-6736
11474-547X
fulltexttrue
rsrctypearticle
creationdate2006
recordtypearticle
recordideNqNktFq1UAQhoMo9lh9BGVREAVTN02ym-iFlKJVKHihgnfLZneSs22SPd3ZFPo6PqmTcw56WsSWXCQTvv8fZuZPkqcZP8h4Jt5-41nBUyFz8YqL16KWnKp7ySIrZJGWhfx5P1n8QfaSR4hnnPNC8PJhspdJXle8yhfJr5PeN7pnerQsQOf8SMXgQ9S9i1esDX5gDs1Sw-AMW4IOkVmHoBHWGozBn9NnjME1U9RNDyx6tnTdEkIal3pM_Sq6YRpY03tvWddPxpPY-NHAGIOO1PMdlcNKz8UlsODwnGlEQBwIeZw8aHWP8GT73k9-fPr4_fhzevr15Mvx0WlqyqqKaaOlraQQwAstgIYueSVrkFWTH9aQm8ZCYWqbt3kLudUFaCPNoSytbWkXkOf7ycuN7yr4iwkwqoEmh77XI_gJlaiyvCzyksDnN8AzPwVaHKqsrrmQRBH0YgN1ugflxtbTrGZ2VEdZLTI6RS3-T9EVS8nF3PDgHxQ9dr6KH6F19P-a7d0EOx3e7AiaCd1I23cj0h0jdnpCvO5_F3zHvdzgJnjEAK1aBTfocKUyruY0q3Wa1RxVxYVap1nNbZ5tFz01A9i_qm18CXh_w9i4uE4Uzev6W-0_bNRAqbp0EBQaBxRL6wKYqKx3tzj8Bl-hGBk
startdate2006
enddate2006
creator
0Danaei, Goodarz
1Lawes, Carlene MM
2Vander Hoorn, Stephen
3Murray, Christopher JL
4Ezzati, Majid
general
0Elsevier Ltd
1Elsevier B.V
2Elsevier Limited
scope
0CGR
1CUY
2CVF
3ECM
4EIF
5NPM
6AAYXX
7CITATION
8BSHEE
90TT
100TZ
110U~
123V.
137QL
147QP
157RV
167TK
177U7
187U9
197X7
207XB
2188A
2288C
2388E
2488G
2588I
268AF
278AO
288C1
298C2
308FE
318FH
328FI
338FJ
348FK
358G5
36ABUWG
37AN0
38ASE
39AZQEC
40BBNVY
41BEC
42BENPR
43BHPHI
44C1K
45DWQXO
46FPQ
47FYUFA
48GHDGH
49GNUQQ
50GUQSH
51H94
52HCIFZ
53K6X
54K9-
55K9.
56KB0
57KB~
58LK8
59M0R
60M0S
61M0T
62M1P
63M2M
64M2O
65M2P
66M7N
67M7P
68MBDVC
69NAPCQ
70PQEST
71PQQKQ
72PQUKI
73Q9U
74S0X
757X8
sort
creationdate2006
titleGlobal and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
authorDanaei, Goodarz ; Lawes, Carlene MM ; Vander Hoorn, Stephen ; Murray, Christopher JL ; Ezzati, Majid
facets
frbrtype5
frbrgroupidcdi_FETCH-LOGICAL-c588t-ba7d8766e04a6e73650879e78b329e3cbde4c9d3f3fe3da4eac7c275ddf980e33
rsrctypearticles
prefilterarticles
languageeng
creationdate2006
topic
0Abridged Index Medicus
1Adult
2Age Distribution
3Aged
4Blood Glucose
5Blood sugar
6Cardiovascular disease
7Complications and side effects
8Diabetes
9Diabetes Mellitus - mortality
10Female
11Global Health
12Health aspects
13Health Surveys
14Heart diseases
15Humans
16Hyperglycemia
17Male
18Measurement
19Middle Aged
20Mortality
21Myocardial ischemia
22Myocardial Ischemia - blood
23Myocardial Ischemia - mortality
24Population Surveillance - methods
25Risk Assessment
26Risk factors
27Sex Distribution
28Stroke (Disease)
29Stroke - blood
30Stroke - mortality
31Studies
32Systematic review
toplevel
0peer_reviewed
1online_resources
creatorcontrib
0Danaei, Goodarz
1Lawes, Carlene MM
2Vander Hoorn, Stephen
3Murray, Christopher JL
4Ezzati, Majid
collection
0Medline
1MEDLINE
2MEDLINE (Ovid)
3MEDLINE
4MEDLINE
5PubMed
6CrossRef
7Academic OneFile (A&I only)
8News PRO
9Pharma and Biotech Premium PRO
10Global News & ABI/Inform Professional
11ProQuest Central (Corporate)
12Bacteriology Abstracts (Microbiology B)
13Calcium & Calcified Tissue Abstracts
14Nursing & Allied Health Database
15Neurosciences Abstracts
16Toxicology Abstracts
17Virology and AIDS Abstracts
18Health & Medical Collection
19ProQuest Central (purchase pre-March 2016)
20Biology Database (Alumni Edition)
21Healthcare Administration Database (Alumni)
22Medical Database (Alumni Edition)
23Psychology Database (Alumni)
24Science Database (Alumni Edition)
25STEM Database
26ProQuest Pharma Collection
27Public Health Database
28Lancet Titles
29ProQuest SciTech Collection
30ProQuest Natural Science Collection
31Hospital Premium Collection
32Hospital Premium Collection (Alumni Edition)
33ProQuest Central (Alumni) (purchase pre-March 2016)
34Research Library (Alumni Edition)
35ProQuest Central (Alumni Edition)
36British Nursing Database
37British Nursing Index
38ProQuest Central Essentials
39Biological Science Collection
40eLibrary
41ProQuest Central
42Natural Science Collection
43Environmental Sciences and Pollution Management
44ProQuest Central Korea
45British Nursing Index (BNI) (1985 to Present)
46Health Research Premium Collection
47Health Research Premium Collection (Alumni)
48ProQuest Central Student
49Research Library Prep
50AIDS and Cancer Research Abstracts
51SciTech Premium Collection
52British Nursing Index
53Consumer Health Database (Alumni Edition)
54ProQuest Health & Medical Complete (Alumni)
55Nursing & Allied Health Database (Alumni Edition)
56ProQuest Newsstand Professional
57ProQuest Biological Science Collection
58Consumer Health Database
59Health & Medical Collection (Alumni Edition)
60Healthcare Administration Database
61Medical Database
62Psychology Database
63Research Library
64Science Database
65Algology Mycology and Protozoology Abstracts (Microbiology C)
66Biological Science Database
67Research Library (Corporate)
68Nursing & Allied Health Premium
69ProQuest One Academic Eastern Edition
70ProQuest One Academic
71ProQuest One Academic UKI Edition
72ProQuest Central Basic
73SIRS Editorial
74MEDLINE - Academic
jtitleThe Lancet (British edition)
delivery
delcategoryRemote Search Resource
fulltextfulltext
addata
au
0Danaei, Goodarz
1Lawes, Carlene MM
2Vander Hoorn, Stephen
3Murray, Christopher JL
4Ezzati, Majid
formatjournal
genrearticle
ristypeJOUR
atitleGlobal and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment
jtitleThe Lancet (British edition)
addtitleLancet
date2006
risdate2006
volume368
issue9548
spage1651
epage1659
pages1651-1659
issn0140-6736
eissn1474-547X
codenLANCAO
abstractCardiovascular mortality risk increases continuously with blood glucose, from concentrations well below conventional thresholds used to define diabetes. We aimed to quantify population-level effects of all higher-than-optimum concentrations of blood glucose on mortality from ischaemic heart disease and stroke worldwide. We used population distribution of fasting plasma glucose to measure exposure to higher-than-optimum blood glucose. We collated exposure data in 52 countries from individual-level records in population health surveys, systematic reviews, and data provided by investigators. Relative risks for ischaemic heart disease and stroke mortality were from a meta-analysis of more than 200 000 participants in the Asia-Pacific region, with adjustment for other cardiovascular risk factors. In addition to 959 000 deaths directly assigned to diabetes, 1 490 000 deaths from ischaemic heart disease and 709 000 from stroke were attributable to high blood glucose, accounting for 21% and 13% of all deaths from these conditions. 1·8 million of these 2·2 million cardiovascular deaths (84%) were in low-and-middle-income countries (1 224 000 for ischaemic heart disease, 623 000 for stroke). 792 000 (53%) of deaths from ischaemic heart disease and 345 000 (49%) from stroke that were attributable to high blood glucose were in men. Largest numbers of deaths attributable to this risk factor from ischaemic heart disease were in low-and-middle-income countries of South Asia (548 000) and Europe and Central Asia (313 000), and from stroke in South Asia (215 000) and East Asia and Pacific (190 000). Higher-than-optimum blood glucose is a leading cause of cardiovascular mortality in most world regions. Programmes for cardiovascular risk and diabetes management and control at the population level need to be more closely integrated.
copEngland
pubElsevier Ltd
pmid17098083
doi10.1016/S0140-6736(06)69700-6